Filing Details

Accession Number:
0000950142-15-000893
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-04-27 18:32:51
Reporting Period:
2015-04-23
Filing Date:
2015-04-27
Accepted Time:
2015-04-27 18:32:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1434868 Esperion Therapeutics Inc. ESPR Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1120478 Md A Dov Goldstein 888 7Th Avenue
30Th Floor
New York NY 10106
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-04-23 150,000 $109.10 1,904,594 No 4 S Indirect By Aisling Capital II, LP
Common Stock Disposition 2015-04-24 5,743 $108.00 1,898,851 No 5 S Indirect By Aisling Capital II, LP
Common Stock Disposition 2015-04-24 61,726 $106.10 1,837,125 No 5 S Indirect By Aisling Capital II, LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Aisling Capital II, LP
No 5 S Indirect By Aisling Capital II, LP
No 5 S Indirect By Aisling Capital II, LP
Footnotes
  1. The reportable securities are owned directly by Aisling Capital II, LP ("Aisling"), and held indirectly by Aisling Capital Partners, LP ("Aisling GP"), as general partner of Aisling, and Aisling Capital Partners, LLC ("Aisling Partners"), as general partner of Aisling GP. Dr. Goldstein is a member of the investment committee of Aisling. Dr. Goldstein disclaims beneficial ownership of these securities and this report is not an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interest therein.